Inorganic impurities analysis is a cornerstone of pharmaceutical analytical chemistry, focusing on the precise identification and quantification of trace metals, elemental impurities, and inorganic salts within drug substances and products. It answers the critical question: "What trace inorganic contaminants are present in the material?" Reliable impurity profiling is essential for ensuring product safety, optimizing synthetic manufacturing routes, and evaluating the quality of raw materials. BOC Sciences offers comprehensive inorganic impurities analysis services utilizing a wide array of advanced analytical instruments and methodologies. We help clients accurately assess catalyst residues, trace elements, and counter ions for small molecules and biologics, providing the robust data needed to confidently secure the quality and purity of therapeutic candidates.
BOC Sciences delivers customized inorganic analysis with rapid turnaround times, helping you make data-driven quality decisions in your drug development pipeline.
We deploy highly sensitive ICP Testing (including ICP-MS and ICP-OES) for the simultaneous, multi-elemental quantification of trace impurities at ultra-low detection limits.
For targeted, single-element analysis, our AAS testing offers an economical and highly specific alternative, particularly useful for routine monitoring of known metallic catalysts.
We utilize non-destructive X-ray fluorescence testing for rapid elemental composition screening of solid samples, powders, and unknown inorganic particulates without extensive sample preparation.
To assess inorganic anions and cations, our ion chromatography testing provides exceptional separation and quantification capabilities, essential for counter ion and salt residue analysis.
Beyond elemental analysis, we incorporate advanced MS testing platforms to assist in identifying complex organometallic impurities or unexpected salt adducts.
We integrate thermal analysis techniques (like TGA and DSC) to determine the residue on ignition (sulfated ash) and evaluate the overall inorganic content profile of a substance.
BOC Sciences adapts sample preparation and analytical designs to suit the unique matrices of various pharmaceutical materials, ensuring accurate inorganic impurity assessment.
Submit your sample details and matrix properties. We will design a bespoke analytical strategy to detect and quantify trace inorganic components with high precision.
Our analytical chemists review your compound's structure, synthetic route, and matrix complexity to recommend the most appropriate digestion techniques and instrumental platforms.
We optimize sample preparation (e.g., closed-vessel microwave digestion) and establish precise analytical parameters to overcome spectral interferences and ensure quantitative recovery.
Analysis is conducted in our controlled laboratory environments. We perform sample testing with rigorous blanks, spikes, and internal standards to ensure data reliability.
Raw instrumental data is evaluated, and exact impurity concentrations are calculated. A comprehensive final report detailing the methodology, recovery rates, and analytical findings is securely delivered.
We assist research teams in confirming the purity of novel synthesized probes or complex inorganic materials. We offer flexible, highly customizable small-batch analytical testing. This tailored approach provides the rigorous, high-quality data necessary for successful peer-reviewed publications, patent filings, and competitive grant applications without straining limited academic budgets.
To help agile startups confidently advance their drug leads, we provide rapid, highly sensitive screening for catalytic metals and trace elements. This enables quick, data-driven modifications to process chemistry, ensuring that initial scale-up batches consistently meet strict safety and purity expectations for early-stage investor milestones.
We seamlessly support large pharmaceutical organizations by efficiently managing high-volume, routine inorganic testing programs to alleviate internal capacity constraints. Alternatively, we step in to solve highly complex analytical challenges, such as forensically tracking down the root source of an unknown elemental contaminant to safeguard mature product lines.
For virtual biotech companies operating without internal analytical wet-lab facilities, we act as a fully integrated, dedicated central laboratory partner. We expertly handle all trace metal, catalyst residue, and inorganic ion testing from early process development right through to the final, complex formulation stages.
Partner with BOC Sciences to access state-of-the-art analytical instrumentation and deep chemical expertise. Our tailored methodologies provide the accurate trace-level data you need to optimize manufacturing and secure the purity of your drug products.
Our laboratories are equipped with the latest generation of ICP-MS, ICP-OES, and Ion Chromatography systems, ensuring unparalleled sensitivity, dynamic range, and resolution for complex sample matrices.
We possess extensive experience in developing custom digestion and extraction protocols, efficiently minimizing polyatomic and physical interferences that commonly plague inorganic analysis.
From trace noble metals to common anionic salts, our diverse technology portfolio allows us to provide a complete and holistic profile of all inorganic species present in your sample.
Every project is executed with stringent scientific oversight. We employ rigorous calibration strategies, blank controls, and matrix spike recoveries to guarantee precision and reproducibility.
Client Needs: A pharmaceutical client utilizing a palladium-catalyzed cross-coupling reaction required rigorous verification that their final purification step successfully cleared the heavy metal catalyst to acceptable trace levels in the isolated Active Pharmaceutical Ingredient.
Challenges: The API was highly insoluble in standard aqueous and weak acid solutions, complicating the sample preparation. Additionally, the required detection limit for palladium was exceptionally low, necessitating high instrumental sensitivity without matrix suppression.
Solution: BOC Sciences developed a tailored closed-vessel microwave digestion protocol using a specialized mixture of concentrated nitric and hydrochloric acids to achieve complete sample dissolution. The analysis was then performed using Inductively Coupled Plasma Mass Spectrometry (ICP-MS) optimized with collision cell technology to remove polyatomic interferences.
Outcome: Our customized method successfully quantified the residual palladium with a robust recovery rate of 98%. The data confirmed that the catalyst was cleared well below the target safety threshold, allowing the client to confidently proceed with batch release.
Client Needs: A biotech firm synthesized a novel small molecule formulation and needed to confirm the exact stoichiometric ratio of the basic API to its chloride counter ion to ensure consistent solubility and bioavailability profiles.
Challenges: Standard elemental analysis techniques were insufficient to differentiate between ionically bound chloride and potential residual free hydrochloric acid trapped within the crystal lattice.
Solution: We deployed a high-resolution Ion Chromatography platform. By carefully designing the extraction procedure using a selective solvent system, we were able to exclusively solubilize the active salt complex. The chromatographic conditions were optimized to provide sharp, distinct peaks for the chloride anion.
Outcome: The precision of our ion chromatography method accurately determined the chloride content, confirming a perfect 1:1 stoichiometric ratio. The resulting data package validated the client's salt formation process and supported their ongoing solid-state characterization efforts.
Client Needs: During routine stability testing, a formulation team observed an unexpected rise in oxidative degradation products in their liquid drug suspension. They suspected trace metal contamination acting as a pro-oxidant catalyst.
Challenges: The formulation contained multiple complex excipients, making it a "dirty" matrix. The team did not know which specific metal was responsible, requiring a broad-spectrum screening approach at ultra-trace levels.
Solution: BOC Sciences conducted a comprehensive multi-elemental scan using ICP-OES and ICP-MS on the degraded formulation, alongside controls of raw excipients and the primary packaging material. We analyzed over 30 elemental targets simultaneously to identify any deviations.
Outcome: Our analysis pinpointed anomalous levels of iron and copper. By cross-referencing the raw material data, we traced the source of the iron contamination to a specific lot of a buffering excipient. The client subsequently switched suppliers, resolving the stability issue entirely.
Inorganic impurities analysis plays a critical role in drug development, particularly in assessing raw material quality, catalyst residues, and metal elements introduced during manufacturing. Through systematic detection and quantification, development teams gain a clearer understanding of material consistency and process stability, helping to minimize variability. Accurate inorganic impurity data also supports better decisions in raw material selection and process optimization. BOC Sciences leverages advanced elemental analysis platforms to provide high-sensitivity, multi-element detection solutions for complex samples.
Inorganic impurities commonly originate from catalyst residues, equipment contact materials, solvent impurities, and metal ions in water sources. Identifying these sources is essential for establishing a robust and consistent process. Control strategies involve not only measuring impurity levels but also tracing their introduction pathways within the process. By optimizing reaction conditions, selecting alternative materials, or improving purification steps, developers can effectively reduce their impact. A systematic approach to impurity analysis helps enhance overall process reliability and product consistency.
Common techniques for inorganic impurities detection include inductively coupled plasma mass spectrometry (ICP-MS), inductively coupled plasma optical emission spectroscopy (ICP-OES), and atomic absorption spectroscopy (AAS). Among these, ICP-MS is widely used for trace-level analysis due to its high sensitivity and capability for simultaneous multi-element detection. Selecting the appropriate technique depends on sample type, target elements, and matrix complexity. BOC Sciences offers multi-platform analytical capabilities and can tailor detection strategies to ensure accurate and reliable results for diverse project needs.
Matrix interference is a common challenge in inorganic impurities analysis, especially for complex samples. Effective sample preparation is crucial, including digestion, dilution, and matrix matching to reduce interference effects. Additionally, techniques such as internal standard correction and collision/reaction cell technology can significantly improve analytical accuracy. By optimizing both sample preparation and instrument parameters, data quality can be greatly enhanced. Experienced service providers can design customized workflows to address matrix-specific challenges and ensure reproducible and trustworthy results.
When selecting an inorganic impurities analysis partner, clients should evaluate the breadth of analytical platforms, method development expertise, and experience in handling complex challenges. A strong partner not only delivers accurate data but also provides meaningful insights aligned with process understanding. Communication efficiency and project comprehension are equally important for smooth collaboration. BOC Sciences has extensive experience in elemental analysis and offers customized support across different stages of drug development, helping clients improve both efficiency and confidence in their analytical data.
We struggled with persistent matrix interferences in our internal catalyst testing. BOC Sciences redesigned our sample preparation and used their advanced ICP-MS platform to deliver pristine, highly reproducible data. Their expertise in inorganic chemistry is unparalleled.
— Dr. Arthur, Lead Process Chemist, Emerging Biotech
Determining the exact counter ion stoichiometry for our new formulation was a major hurdle. The ion chromatography results from BOC Sciences were clear, precise, and delivered exactly when we needed them to finalize our solid-form selection strategy.
— Dr. Lucas, Formulation Scientist, Pharmaceutical Company
When we detected an unknown precipitate in a pilot batch, we needed answers immediately. BOC Sciences performed an rapid elemental scan and identified the inorganic contaminant within days, allowing us to correct our manufacturing process without significant delays.
— Dr. James, Manufacturing Project Leader, Drug Discovery Institute
The team at BOC Sciences doesn't just run samples; they partner with you. Their proactive advice on how to handle our highly volatile inorganic intermediates prevented major sample loss and ensured the analytical data accurately reflected our material's true purity.
— Dr. Thomas, VP of Analytical Development, Therapeutics Startup
If you have any questions or encounter issues on this page, please don't hesitate to reach out. Our support team is ready to assist you.
